Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases
Objectives The contribution of adaptive vs. innate lymphocytes to IL-17A and IL-22 secretion at the end stage of chronic lung diseases remains largely unexplored. In order to uncover tissue- and disease-specific secretion patterns, we compared production patterns of IL-17A and IL-22 in three differe...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 June 2022
|
| In: |
Clinical & Translational Immunology
Year: 2022, Jahrgang: 11, Heft: 6, Pages: 1-18 |
| ISSN: | 2050-0068 |
| DOI: | 10.1002/cti2.1398 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/cti2.1398 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cti2.1398 
|
| Verfasserangaben: | Melanie Albrecht, Olga Halle, Svenja Gaedcke, Sophia T Pallenberg, Julia Camargo Neumann, Marius Witt, Johanna Roediger, Marina Schumacher, Adan Chari Jirmo, Gregor Warnecke, Danny Jonigk, Peter Braubach, David DeLuca, Gesine Hansen & Anna-Maria Dittrich |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1811982255 | ||
| 003 | DE-627 | ||
| 005 | 20230427152916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220729s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cti2.1398 |2 doi | |
| 035 | |a (DE-627)1811982255 | ||
| 035 | |a (DE-599)KXP1811982255 | ||
| 035 | |a (OCoLC)1341464594 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Albrecht, Melanie |d 1979- |e VerfasserIn |0 (DE-588)139361030 |0 (DE-627)610255525 |0 (DE-576)311372783 |4 aut | |
| 245 | 1 | 0 | |a Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases |c Melanie Albrecht, Olga Halle, Svenja Gaedcke, Sophia T Pallenberg, Julia Camargo Neumann, Marius Witt, Johanna Roediger, Marina Schumacher, Adan Chari Jirmo, Gregor Warnecke, Danny Jonigk, Peter Braubach, David DeLuca, Gesine Hansen & Anna-Maria Dittrich |
| 264 | 1 | |c 16 June 2022 | |
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.07.2022 | ||
| 520 | |a Objectives The contribution of adaptive vs. innate lymphocytes to IL-17A and IL-22 secretion at the end stage of chronic lung diseases remains largely unexplored. In order to uncover tissue- and disease-specific secretion patterns, we compared production patterns of IL-17A and IL-22 in three different human end-stage lung disease entities. Methods Production of IL-17A, IL-22 and associated cytokines was assessed in supernatants of re-stimulated lymphocytes by multiplex assays and multicolour flow cytometry of conventional T cells, iNKT cells, γδ T cells and innate lymphoid cells in bronchial lymph node and lung tissue from patients with emphysema (n = 19), idiopathic pulmonary fibrosis (n = 14) and cystic fibrosis (n = 23), as well as lung donors (n = 17). Results We detected secretion of IL-17A and IL-22 by CD4+ T cells, CD8+ T cells, innate lymphoid cells, γδ T cells and iNKT cells in all end-stage lung disease entities. Our analyses revealed disease-specific contributions of individual lymphocyte subpopulations to cytokine secretion patterns. We furthermore found the high levels of microbial detection in CF samples to associate with a more pronounced IL-17A signature upon antigen-specific and unspecific re-stimulation compared to other disease entities and lung donors. Conclusion Our results show that both adaptive and innate lymphocyte populations contribute to IL-17A-dependent pathologies in different end-stage lung disease entities, where they establish an IL-17A-rich microenvironment. Microbial colonisation patterns and cytokine secretion upon microbial re-stimulation suggest that pathogens drive IL-17A secretion patterns in end-stage lung disease. | ||
| 650 | 4 | |a cystic fibrosis | |
| 650 | 4 | |a end-stage lung disease | |
| 650 | 4 | |a IL-17 | |
| 650 | 4 | |a innate lymphoid cells | |
| 700 | 1 | |a Halle, Olga |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gaedcke, Svenja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pallenberg, Sophia T |e VerfasserIn |4 aut | |
| 700 | 1 | |a Camargo Neumann, Julia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Witt, Marius |e VerfasserIn |4 aut | |
| 700 | 1 | |a Roediger, Johanna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schumacher, Marina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jirmo, Adan Chari |e VerfasserIn |4 aut | |
| 700 | 1 | |a Warnecke, Gregor |d 1974- |e VerfasserIn |0 (DE-588)125001517 |0 (DE-627)370699629 |0 (DE-576)294612823 |4 aut | |
| 700 | 1 | |a Jonigk, Danny |e VerfasserIn |4 aut | |
| 700 | 1 | |a Braubach, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a DeLuca, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hansen, Gesine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dittrich, Anna-Maria |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical & Translational Immunology |d Hoboken, NJ : Wiley, 2012 |g 11(2022), 6, Artikel-ID e1398, Seite 1-18 |h Online-Ressource |w (DE-627)731890310 |w (DE-600)2694482-0 |w (DE-576)376352361 |x 2050-0068 |7 nnas |a Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:6 |g elocationid:e1398 |g pages:1-18 |g extent:18 |a Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases |
| 856 | 4 | 0 | |u https://doi.org/10.1002/cti2.1398 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/cti2.1398 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220729 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 125001517 |a Warnecke, Gregor |m 125001517:Warnecke, Gregor |d 910000 |d 910200 |e 910000PW125001517 |e 910200PW125001517 |k 0/910000/ |k 1/910000/910200/ |p 10 | ||
| 999 | |a KXP-PPN1811982255 |e 4173737068 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Melanie Albrecht, Olga Halle, Svenja Gaedcke, Sophia T Pallenberg, Julia Camargo Neumann, Marius Witt, Johanna Roediger, Marina Schumacher, Adan Chari Jirmo, Gregor Warnecke, Danny Jonigk, Peter Braubach, David DeLuca, Gesine Hansen & Anna-Maria Dittrich"]},"id":{"doi":["10.1002/cti2.1398"],"eki":["1811982255"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"16 June 2022"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2694482-0"],"eki":["731890310"],"issn":["2050-0068"]},"origin":[{"publisher":"Wiley ; Nature Publ. Group","dateIssuedKey":"2012","dateIssuedDisp":"2012-","publisherPlace":"Hoboken, NJ ; London"}],"name":{"displayForm":["Australasian Society for Immunology"]},"titleAlt":[{"title":"Clinical and Translational Immunology"}],"part":{"volume":"11","text":"11(2022), 6, Artikel-ID e1398, Seite 1-18","extent":"18","year":"2022","issue":"6","pages":"1-18"},"pubHistory":["1.2012 -"],"language":["eng"],"recId":"731890310","note":["Gesehen am 02.03.2018"],"disp":"Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseasesClinical & Translational Immunology","type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"Clinical & Translational Immunology","title_sort":"Clinical & Translational Immunology"}]}],"physDesc":[{"extent":"18 S."}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Albrecht, Melanie","given":"Melanie","family":"Albrecht"},{"display":"Halle, Olga","roleDisplay":"VerfasserIn","role":"aut","family":"Halle","given":"Olga"},{"given":"Svenja","family":"Gaedcke","role":"aut","roleDisplay":"VerfasserIn","display":"Gaedcke, Svenja"},{"role":"aut","display":"Pallenberg, Sophia T","roleDisplay":"VerfasserIn","given":"Sophia T","family":"Pallenberg"},{"given":"Julia","family":"Camargo Neumann","role":"aut","roleDisplay":"VerfasserIn","display":"Camargo Neumann, Julia"},{"role":"aut","display":"Witt, Marius","roleDisplay":"VerfasserIn","given":"Marius","family":"Witt"},{"given":"Johanna","family":"Roediger","role":"aut","display":"Roediger, Johanna","roleDisplay":"VerfasserIn"},{"family":"Schumacher","given":"Marina","display":"Schumacher, Marina","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Adan Chari","family":"Jirmo","role":"aut","roleDisplay":"VerfasserIn","display":"Jirmo, Adan Chari"},{"role":"aut","display":"Warnecke, Gregor","roleDisplay":"VerfasserIn","given":"Gregor","family":"Warnecke"},{"given":"Danny","family":"Jonigk","role":"aut","display":"Jonigk, Danny","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Braubach, Peter","role":"aut","family":"Braubach","given":"Peter"},{"role":"aut","display":"DeLuca, David","roleDisplay":"VerfasserIn","given":"David","family":"DeLuca"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Hansen, Gesine","given":"Gesine","family":"Hansen"},{"given":"Anna-Maria","family":"Dittrich","role":"aut","roleDisplay":"VerfasserIn","display":"Dittrich, Anna-Maria"}],"title":[{"title":"Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases","title_sort":"Interleukin-17A and interleukin-22 production by conventional and non-conventional lymphocytes in three different end-stage lung diseases"}],"language":["eng"],"recId":"1811982255","note":["Gesehen am 29.07.2022"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a ALBRECHTMEINTERLEUKI1620 | ||